Industry Research Reports
Home > Reports > Chemical & Material > Lenalidomide API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Lenalidomide API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Industry: Chemical & Material
Published Date: 2024-02-23
Pages: 97 Pages
Report ld: 2578286
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
The global market for Lenalidomide API was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Lenalidomide API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lenalidomide API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Lenalidomide API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Lenalidomide API include Dr. Reddy’s Laboratories Ltd., Johnson Matthey PLC, Changzhou Pharmaceutical Factory, Shilpa Medicare Limited, Biocon Limited, Sun Pharmaceutical Industries Ltd., Shenzhen Haorui and Mac-Chem Products (India) Pvt.Ltd, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
MARKET SEGMENTATION
By Company
- Dr. Reddy’s Laboratories Ltd.
- Johnson Matthey PLC
- Changzhou Pharmaceutical Factory
- Shilpa Medicare Limited
- Biocon Limited
- Sun Pharmaceutical Industries Ltd.
- Shenzhen Haorui
- Mac-Chem Products (India) Pvt.Ltd
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity≥98%
- Purity<98%
Segment by Application
- Lenalidomide capsules
- Others
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Lenalidomide API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Lenalidomide API by region & country, by Type, and by Application.
The Lenalidomide API market size, estimations, and forecasts are provided in terms of sales volume (Ton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lenalidomide API.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Lenalidomide API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Lenalidomide API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Lenalidomide API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Lenalidomide API Product Introduction
1.2 Global Lenalidomide API Market Size Forecast
1.2.1 Global Lenalidomide API Sales Value (2019-2030)
1.2.2 Global Lenalidomide API Sales Volume (2019-2030)
1.2.3 Global Lenalidomide API Sales Price (2019-2030)
1.3 Lenalidomide API Market Trends & Drivers
1.3.1 Lenalidomide API Industry Trends
1.3.2 Lenalidomide API Market Drivers & Opportunity
1.3.3 Lenalidomide API Market Challenges
1.3.4 Lenalidomide API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Lenalidomide API Players Revenue Ranking (2023)
2.2 Global Lenalidomide API Revenue by Company (2019-2024)
2.3 Global Lenalidomide API Players Sales Volume Ranking (2023)
2.4 Global Lenalidomide API Sales Volume by Company Players (2019-2024)
2.5 Global Lenalidomide API Average Price by Company (2019-2024)
2.6 Key Manufacturers Lenalidomide API Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Lenalidomide API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Lenalidomide API
2.9 Lenalidomide API Market Competitive Analysis
2.9.1 Lenalidomide API Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Lenalidomide API Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lenalidomide API as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity≥98%
3.1.2 Purity<98%
3.2 Global Lenalidomide API Sales Value by Type
3.2.1 Global Lenalidomide API Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Lenalidomide API Sales Value, by Type (2019-2030)
3.2.3 Global Lenalidomide API Sales Value, by Type (%) (2019-2030)
3.3 Global Lenalidomide API Sales Volume by Type
3.3.1 Global Lenalidomide API Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Lenalidomide API Sales Volume, by Type (2019-2030)
3.3.3 Global Lenalidomide API Sales Volume, by Type (%) (2019-2030)
3.4 Global Lenalidomide API Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Lenalidomide capsules
4.1.2 Others
4.2 Global Lenalidomide API Sales Value by Application
4.2.1 Global Lenalidomide API Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Lenalidomide API Sales Value, by Application (2019-2030)
4.2.3 Global Lenalidomide API Sales Value, by Application (%) (2019-2030)
4.3 Global Lenalidomide API Sales Volume by Application
4.3.1 Global Lenalidomide API Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Lenalidomide API Sales Volume, by Application (2019-2030)
4.3.3 Global Lenalidomide API Sales Volume, by Application (%) (2019-2030)
4.4 Global Lenalidomide API Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Lenalidomide API Sales Value by Region
5.1.1 Global Lenalidomide API Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Lenalidomide API Sales Value by Region (2019-2024)
5.1.3 Global Lenalidomide API Sales Value by Region (2025-2030)
5.1.4 Global Lenalidomide API Sales Value by Region (%), (2019-2030)
5.2 Global Lenalidomide API Sales Volume by Region
5.2.1 Global Lenalidomide API Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Lenalidomide API Sales Volume by Region (2019-2024)
5.2.3 Global Lenalidomide API Sales Volume by Region (2025-2030)
5.2.4 Global Lenalidomide API Sales Volume by Region (%), (2019-2030)
5.3 Global Lenalidomide API Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Lenalidomide API Sales Value, 2019-2030
5.4.2 North America Lenalidomide API Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Lenalidomide API Sales Value, 2019-2030
5.5.2 Europe Lenalidomide API Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Lenalidomide API Sales Value, 2019-2030
5.6.2 Asia Pacific Lenalidomide API Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Lenalidomide API Sales Value, 2019-2030
5.7.2 South America Lenalidomide API Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Lenalidomide API Sales Value, 2019-2030
5.8.2 Middle East & Africa Lenalidomide API Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Lenalidomide API Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Lenalidomide API Sales Value
6.2.1 Key Countries/Regions Lenalidomide API Sales Value, 2019-2030
6.2.2 Key Countries/Regions Lenalidomide API Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Lenalidomide API Sales Value, 2019-2030
6.3.2 United States Lenalidomide API Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Lenalidomide API Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Lenalidomide API Sales Value, 2019-2030
6.4.2 Europe Lenalidomide API Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Lenalidomide API Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Lenalidomide API Sales Value, 2019-2030
6.5.2 China Lenalidomide API Sales Value by Type (%), 2023 VS 2030
6.5.3 China Lenalidomide API Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Lenalidomide API Sales Value, 2019-2030
6.6.2 Japan Lenalidomide API Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Lenalidomide API Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Lenalidomide API Sales Value, 2019-2030
6.7.2 South Korea Lenalidomide API Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Lenalidomide API Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Lenalidomide API Sales Value, 2019-2030
6.8.2 Southeast Asia Lenalidomide API Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Lenalidomide API Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Lenalidomide API Sales Value, 2019-2030
6.9.2 India Lenalidomide API Sales Value by Type (%), 2023 VS 2030
6.9.3 India Lenalidomide API Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Dr. Reddy’s Laboratories Ltd.
7.1.1 Dr. Reddy’s Laboratories Ltd. Company Information
7.1.2 Dr. Reddy’s Laboratories Ltd. Introduction and Business Overview
7.1.3 Dr. Reddy’s Laboratories Ltd. Lenalidomide API Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Dr. Reddy’s Laboratories Ltd. Lenalidomide API Product Offerings
7.1.5 Dr. Reddy’s Laboratories Ltd. Recent Development
7.2 Johnson Matthey PLC
7.2.1 Johnson Matthey PLC Company Information
7.2.2 Johnson Matthey PLC Introduction and Business Overview
7.2.3 Johnson Matthey PLC Lenalidomide API Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Johnson Matthey PLC Lenalidomide API Product Offerings
7.2.5 Johnson Matthey PLC Recent Development
7.3 Changzhou Pharmaceutical Factory
7.3.1 Changzhou Pharmaceutical Factory Company Information
7.3.2 Changzhou Pharmaceutical Factory Introduction and Business Overview
7.3.3 Changzhou Pharmaceutical Factory Lenalidomide API Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Changzhou Pharmaceutical Factory Lenalidomide API Product Offerings
7.3.5 Changzhou Pharmaceutical Factory Recent Development
7.4 Shilpa Medicare Limited
7.4.1 Shilpa Medicare Limited Company Information
7.4.2 Shilpa Medicare Limited Introduction and Business Overview
7.4.3 Shilpa Medicare Limited Lenalidomide API Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Shilpa Medicare Limited Lenalidomide API Product Offerings
7.4.5 Shilpa Medicare Limited Recent Development
7.5 Biocon Limited
7.5.1 Biocon Limited Company Information
7.5.2 Biocon Limited Introduction and Business Overview
7.5.3 Biocon Limited Lenalidomide API Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Biocon Limited Lenalidomide API Product Offerings
7.5.5 Biocon Limited Recent Development
7.6 Sun Pharmaceutical Industries Ltd.
7.6.1 Sun Pharmaceutical Industries Ltd. Company Information
7.6.2 Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
7.6.3 Sun Pharmaceutical Industries Ltd. Lenalidomide API Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Sun Pharmaceutical Industries Ltd. Lenalidomide API Product Offerings
7.6.5 Sun Pharmaceutical Industries Ltd. Recent Development
7.7 Shenzhen Haorui
7.7.1 Shenzhen Haorui Company Information
7.7.2 Shenzhen Haorui Introduction and Business Overview
7.7.3 Shenzhen Haorui Lenalidomide API Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Shenzhen Haorui Lenalidomide API Product Offerings
7.7.5 Shenzhen Haorui Recent Development
7.8 Mac-Chem Products (India) Pvt.Ltd
7.8.1 Mac-Chem Products (India) Pvt.Ltd Company Information
7.8.2 Mac-Chem Products (India) Pvt.Ltd Introduction and Business Overview
7.8.3 Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Product Offerings
7.8.5 Mac-Chem Products (India) Pvt.Ltd Recent Development
8 Industry Chain Analysis
8.1 Lenalidomide API Industrial Chain
8.2 Lenalidomide API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Lenalidomide API Sales Model
8.5.2 Sales Channel
8.5.3 Lenalidomide API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Lenalidomide API Market Trends
Table 2. Lenalidomide API Market Drivers & Opportunity
Table 3. Lenalidomide API Market Challenges
Table 4. Lenalidomide API Market Restraints
Table 5. Global Lenalidomide API Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Lenalidomide API Revenue Market Share by Company (2019-2024)
Table 7. Global Lenalidomide API Sales Volume by Company (2019-2024) & (Ton)
Table 8. Global Lenalidomide API Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Lenalidomide API Price by Company (2019-2024) & (US$/Ton)
Table 10. Key Manufacturers Lenalidomide API Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Lenalidomide API Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Lenalidomide API
Table 13. Global Lenalidomide API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lenalidomide API as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Lenalidomide API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Lenalidomide API Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Lenalidomide API Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Lenalidomide API Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Lenalidomide API Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Lenalidomide API Sales Volume by Type: 2019 VS 2023 VS 2030 (Ton)
Table 22. Global Lenalidomide API Sales Volume by Type (2019-2024) & (Ton)
Table 23. Global Lenalidomide API Sales Volume by Type (2025-2030) & (Ton)
Table 24. Global Lenalidomide API Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Lenalidomide API Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Lenalidomide API Price by Type (2019-2024) & (US$/Ton)
Table 27. Global Lenalidomide API Price by Type (2025-2030) & (US$/Ton)
Table 28. Global Lenalidomide API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Lenalidomide API Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Lenalidomide API Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Lenalidomide API Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Lenalidomide API Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Lenalidomide API Sales Volume by Application: 2019 VS 2023 VS 2030 (Ton)
Table 34. Global Lenalidomide API Sales Volume by Application (2019-2024) & (Ton)
Table 35. Global Lenalidomide API Sales Volume by Application (2025-2030) & (Ton)
Table 36. Global Lenalidomide API Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Lenalidomide API Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Lenalidomide API Price by Application (2019-2024) & (US$/Ton)
Table 39. Global Lenalidomide API Price by Application (2025-2030) & (US$/Ton)
Table 40. Global Lenalidomide API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Lenalidomide API Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Lenalidomide API Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Lenalidomide API Sales Value by Region (2019-2024) & (%)
Table 44. Global Lenalidomide API Sales Value by Region (2025-2030) & (%)
Table 45. Global Lenalidomide API Sales Volume by Region (Ton): 2019 VS 2023 VS 2030
Table 46. Global Lenalidomide API Sales Volume by Region (2019-2024) & (Ton)
Table 47. Global Lenalidomide API Sales Volume by Region (2025-2030) & (Ton)
Table 48. Global Lenalidomide API Sales Volume by Region (2019-2024) & (%)
Table 49. Global Lenalidomide API Sales Volume by Region (2025-2030) & (%)
Table 50. Global Lenalidomide API Average Price by Region (2019-2024) & (US$/Ton)
Table 51. Global Lenalidomide API Average Price by Region (2025-2030) & (US$/Ton)
Table 52. Key Countries/Regions Lenalidomide API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Lenalidomide API Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Lenalidomide API Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Lenalidomide API Sales Volume, (2019-2024) & (Ton)
Table 56. Key Countries/Regions Lenalidomide API Sales Volume, (2025-2030) & (Ton)
Table 57. Dr. Reddy’s Laboratories Ltd. Company Information
Table 58. Dr. Reddy’s Laboratories Ltd. Introduction and Business Overview
Table 59. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 60. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Product Offerings
Table 61. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 62. Johnson Matthey PLC Company Information
Table 63. Johnson Matthey PLC Introduction and Business Overview
Table 64. Johnson Matthey PLC Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 65. Johnson Matthey PLC Lenalidomide API Product Offerings
Table 66. Johnson Matthey PLC Recent Development
Table 67. Changzhou Pharmaceutical Factory Company Information
Table 68. Changzhou Pharmaceutical Factory Introduction and Business Overview
Table 69. Changzhou Pharmaceutical Factory Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 70. Changzhou Pharmaceutical Factory Lenalidomide API Product Offerings
Table 71. Changzhou Pharmaceutical Factory Recent Development
Table 72. Shilpa Medicare Limited Company Information
Table 73. Shilpa Medicare Limited Introduction and Business Overview
Table 74. Shilpa Medicare Limited Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 75. Shilpa Medicare Limited Lenalidomide API Product Offerings
Table 76. Shilpa Medicare Limited Recent Development
Table 77. Biocon Limited Company Information
Table 78. Biocon Limited Introduction and Business Overview
Table 79. Biocon Limited Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 80. Biocon Limited Lenalidomide API Product Offerings
Table 81. Biocon Limited Recent Development
Table 82. Sun Pharmaceutical Industries Ltd. Company Information
Table 83. Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 84. Sun Pharmaceutical Industries Ltd. Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 85. Sun Pharmaceutical Industries Ltd. Lenalidomide API Product Offerings
Table 86. Sun Pharmaceutical Industries Ltd. Recent Development
Table 87. Shenzhen Haorui Company Information
Table 88. Shenzhen Haorui Introduction and Business Overview
Table 89. Shenzhen Haorui Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. Shenzhen Haorui Lenalidomide API Product Offerings
Table 91. Shenzhen Haorui Recent Development
Table 92. Mac-Chem Products (India) Pvt.Ltd Company Information
Table 93. Mac-Chem Products (India) Pvt.Ltd Introduction and Business Overview
Table 94. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 95. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Product Offerings
Table 96. Mac-Chem Products (India) Pvt.Ltd Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Lenalidomide API Downstream Customers
Table 100. Lenalidomide API Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Lenalidomide API Product Picture
Figure 2. Global Lenalidomide API Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Lenalidomide API Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Lenalidomide API Sales Volume (2019-2030) & (Ton)
Figure 5. Global Lenalidomide API Sales Price (2019-2030) & (US$/Ton)
Figure 6. Lenalidomide API Report Years Considered
Figure 7. Global Lenalidomide API Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Lenalidomide API Players Sales Volume Ranking (2023) & (Ton)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Lenalidomide API Revenue in 2023
Figure 10. Lenalidomide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Purity≥98% Picture
Figure 12. Purity<98% Picture
Figure 13. Global Lenalidomide API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Lenalidomide API Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Lenalidomide API Sales Volume by Type (2019 VS 2023 VS 2030) & (Ton)
Figure 16. Global Lenalidomide API Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Lenalidomide API Price by Type (2019-2030) & (US$/Ton)
Figure 18. Product Picture of Lenalidomide capsules
Figure 19. Product Picture of Others
Figure 20. Global Lenalidomide API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Lenalidomide API Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Lenalidomide API Sales Volume by Application (2019 VS 2023 VS 2030) & (Ton)
Figure 23. Global Lenalidomide API Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Lenalidomide API Price by Application (2019-2030) & (US$/Ton)
Figure 25. North America Lenalidomide API Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Lenalidomide API Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Lenalidomide API Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Lenalidomide API Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Lenalidomide API Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Lenalidomide API Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Lenalidomide API Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Lenalidomide API Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Lenalidomide API Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Lenalidomide API Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Lenalidomide API Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Lenalidomide API Sales Volume (%), (2019-2030)
Figure 37. United States Lenalidomide API Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Lenalidomide API Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Lenalidomide API Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Lenalidomide API Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Lenalidomide API Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Lenalidomide API Sales Value by Application (%), 2023 VS 2030
Figure 43. China Lenalidomide API Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Lenalidomide API Sales Value by Type (%), 2023 VS 2030
Figure 45. China Lenalidomide API Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Lenalidomide API Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Lenalidomide API Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Lenalidomide API Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Lenalidomide API Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Lenalidomide API Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Lenalidomide API Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Lenalidomide API Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Lenalidomide API Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Lenalidomide API Sales Value by Application (%), 2023 VS 2030
Figure 55. India Lenalidomide API Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Lenalidomide API Sales Value by Type (%), 2023 VS 2030
Figure 57. India Lenalidomide API Sales Value by Application (%), 2023 VS 2030
Figure 58. Lenalidomide API Industrial Chain
Figure 59. Lenalidomide API Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Lenalidomide API market?
The top companies in the global Lenalidomide API market are Dr. Reddy’s Laboratories Ltd.、Johnson Matthey PLC、Changzhou Pharmaceutical Factory.
Related Reports
Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lenalidomide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 126
USD 3950.00
(Single User License)
Global Lenalidomide API Market Research Report 2026
The global Lenalidomide API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 134
USD 2900.00
(Single User License)
Global Lenalidomide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lenalidomide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 139
USD 4900.00
(Single User License)
Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lenalidomide API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 99
USD 3950.00
(Single User License)
Global Lenalidomide API Market Research Report 2025
The global market for Lenalidomide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 95
USD 2900.00
(Single User License)
Global Lenalidomide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lenalidomide API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 77
USD 4250.00
(Single User License)
Global Lenalidomide API Market Insights, Forecast to 2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published Date: 2024-04-15
Pages: 95
USD 4900.00
(Single User License)
Global Lenalidomide API Market Research Report 2024
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published Date: 2024-01-10
Pages: 85
USD 2900.00
(Single User License)
Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lenalidomide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 126
USD 3950.00 (Single User License)Global Lenalidomide API Market Research Report 2026
The global Lenalidomide API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 134
USD 2900.00 (Single User License)Global Lenalidomide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lenalidomide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 139
USD 4900.00 (Single User License)Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lenalidomide API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 99
USD 3950.00 (Single User License)Global Lenalidomide API Market Research Report 2025
The global market for Lenalidomide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 95
USD 2900.00 (Single User License)Global Lenalidomide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lenalidomide API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 77
USD 4250.00 (Single User License)Global Lenalidomide API Market Insights, Forecast to 2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published: 2024-04-15
Pages: 95
USD 4900.00 (Single User License)Global Lenalidomide API Market Research Report 2024
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published: 2024-01-10
Pages: 85
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now